Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
High-risk multiple myeloma patients who complete pre-transplant induction treatment anti-myeloma drug combination (minimum 2 drugs).
Patients must be 18 years of age or older at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is testing a new treatment for myeloma patients who still have some disease remaining after induction therapy. The goal is to see if this new treatment can help these patients achieve a complete response.
Who is the study for?
This trial is for adults over 18 with high-risk multiple myeloma who still have signs of the disease after initial drug treatment. It's not open to pregnant or breastfeeding individuals, nor those with uncontrolled infections.Check my eligibility
What is being tested?
The trial is testing Descartes-08 as a consolidation treatment to see if it can fully clear any remaining myeloma cells in patients who've already undergone induction therapy.See study design
What are the potential side effects?
Potential side effects of Descartes-08 are not specified here, but similar treatments may cause immune reactions, fatigue, nausea, and increased risk of infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have high-risk multiple myeloma and finished a treatment with at least 2 drugs before a stem cell transplant.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of stringent complete response
Trial Design
1Treatment groups
Experimental Treatment
Group I: Descartes 08Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Cartesian TherapeuticsLead Sponsor
8 Previous Clinical Trials
218 Total Patients Enrolled
5 Trials studying Multiple Myeloma
128 Patients Enrolled for Multiple Myeloma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have high-risk multiple myeloma and finished a treatment with at least 2 drugs before a stem cell transplant.I am 18 years old or older.I do not have any active and uncontrolled infections.
Research Study Groups:
This trial has the following groups:- Group 1: Descartes 08
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger